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URL: http://biology.nuim.ie (S. Doyle).Although initially investigated for its antifungal properties, little is actually known about the effect of
gliotoxin on Aspergillus fumigatus and other fungi. We have observed that exposure of A. fumigatus to
exogenous gliotoxin (14 lg/ml), under gliotoxin-limited growth conditions, results in significant alter-
ation of the expression of 27 proteins (up- and down-regulated >1.9-fold; p < 0.05) including de novo
expression of Cu, Zn superoxide dismutase, up-regulated allergen Asp f3 expression and down-regulated
catalase and a peroxiredoxin levels. Significantly elevated glutathione GSH levels (p < 0.05), along with
concomitant resistance to diamide, were evident in A. fumigatus DgliT, lacking gliotoxin oxidoreductase,
a gliotoxin self-protection gene. Saccharomyces cerevisiae deletents (Dsod1 and Dyap1) were hypersensi-
tive to exogenous gliotoxin, while Dgsh1 was resistant. Significant gliotoxin-mediated (5 lg/ml) growth
inhibition (p < 0.001) of Aspergillus nidulans, Aspergillus terreus, Aspergillus niger, Cochliobolus heterostro-
phus and Neurospora crassa was also observed. Growth of Aspergillus flavus, Fusarium graminearum and
Aspergillus oryzae was significantly inhibited (p < 0.001) at gliotoxin (10 lg/ml), indicating differential
gliotoxin sensitivity amongst fungi. Re-introduction of gliT into A. fumigatus DgliT, at a different locus
(ctsD; AFUA_4G07040, an aspartic protease), with selection on gliotoxin, facilitated deletion of ctsD with-
out use of additional antibiotic selection markers. Absence of ctsD expression was accompanied by res-
toration of gliT expression, and resistance to gliotoxin. Thus, we propose gliT/gliotoxin as a useful
selection marker system for fungal transformation. Finally, we suggest incorporation of gliotoxin sensi-
tivity assays into all future fungal functional genomic studies.
 2012 Elsevier Inc. All rights reserved.1. Introduction
Production of gliotoxin, an epipolythiodioxopiperazine, by
Aspergillus fumigatus is enabled by a 28 kb gene cluster (gli) located
on chromosome 6 (Gardiner et al., 2004; Cramer et al., 2006). The
molecule has been intensively studied because of its cytotoxic, im-
muno-inhibitory and apoptotic effects on animal cells (Sutton
et al., 1994). Gliotoxin has recently been shown to inhibit angio-
genesis and it has been proposed that this effect prevents tissue
neovascularisation, impedes the proinflammatory response and
contributes to tissue damage (Ben-ami et al., 2009). As a result of
disulphide bridge presence, gliotoxin is a redox active molecule
and can cycle between the oxidised and reduced forms depending
on the cellular redox state (Waring et al., 1995). In an elegant set of
experiments, Bernardo et al. (2003) demonstrated that the oxi-
dised form of gliotoxin is taken up by mammalian cells, undergoes
glutathione (GSH)-mediated reduction to the reduced form, which
ultimately re-oxidises upon depletion of intracellular GSH and isll rights reserved.effluxed from the cell. Deletion of gliZ (Bok et al., 2006) and gliP
(Cramer et al., 2006; Kupfahl et al., 2006), gliT (Schrettl et al.,
2010; Scharf et al., 2010) and gliG (Davis et al., 2011) respectively,
abolishes gliotoxin production by A. fumigatus. Indeed, Cramer
et al. (2006) demonstrated that exogenous gliotoxin controlled
the expression of the gli cluster in A. fumigatus and thereby regu-
lated its own production.
Chamilos et al. (2008) studied the effect of gliotoxin on Saccha-
romyces cerevisiae, using a library of single-gene mutants (4787
strains), in an attempt to further elucidate mechanisms of gliotoxin
cytotoxicity and identify novel drug targets in eukaryotic cells.
Overall, 10 mutants exhibited increased resistance to gliotoxin
while 3 were statistically more sensitive to exogenous gliotoxin,
compared to wild-type. Increased resistance to gliotoxin was
observed in strains lacking genes encoding metabolic, vesicular
transport, DNA damage repair and unknown function functions,
while increased sensitivity was evident when Cys3, a cystathionine
gamma-lyase and Mef1 a transcriptional elongation factor of mito-
chondrial origin were absent.
Rohlfs et al. (2007) demonstrated that toxic secondary metabo-
lites produced by Aspergillus nidulans, under control of the global
regulator laeA, significantly discouraged feeding by the fungivore,
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ondary metabolite biosynthesis in fungi. This led Kwon-Chung
and Sugui (2009) to note that production of secondary metabolites
might improve the survival chances of fungi. Moreover, although
secondary metabolite production may also be influenced by com-
petition between different fungal species, until recently, it was
not known if secondary metabolites produced by Aspergilli con-
ferred a growth competitive advantage in the presence of related
species (Losada et al., 2009). Although these authors identified a
number of secreted metabolites, which may contribute to im-
proved survival, no information with respect to individual metab-
olite potency, or the effect on non-Aspergillus spp. was presented.
Losada et al. postulated that resistance genes would be required
to allow a toxin producer to grow in the presence of its metabolite
weaponry and it has now been shown that gliT in the gli cluster
mediates self-protection against exogenous gliotoxin in A. fumiga-
tus (Schrettl et al., 2010; Scharf et al., 2010) whereby a gliT-defi-
cient strain was unable to grow in the presence of gliotoxin. In
fact, gliT is the key resistance gene against gliotoxin in A. fumigatus
and Schrettl et al. demonstrated that DgliT complementation was
possible using selection on gliotoxin-containing media without
additional antibiotics (e.g., hygromycin or phleomycin). However,
use of gliT re-introduction into A. fumigatus DgliT, and subsequent
selection in gliotoxin presence, for the targeted deletion of
unrelated genes has not been demonstrated.
Thus, a new paradigm has emerged where the effects, and role,
of gliotoxin in A. fumigatus, in particular, and fungi generally, re-
quires investigation: as it may represent a novel probe to further
our understanding of the function of ETPs, and redox control mech-
anisms, in fungi. In addition, exploitation of the effects of gliotoxin
to develop a new fungal selection marker system may be feasible.2. Materials and methods
2.1. Extraction of gliotoxin from culture filtrates
A. fumigatus ATCC26933 (1  105 cfu/ml) was grown for 24 h in
either Minimal Essential Medium (plus 5% (v/v) fetal calf serum
(MEM/FCS)) or Sabouraud media (25 ml cultures), at 37 C with
shaking at 200 rpm. Supernatants were separated by filtration
and an equal volume of extraction buffer (ethyl acetate:chloro-
form:methanol, 3:2:1) was added. After overnight incubation at
4 C, filtrates were centrifuged and organic layers removed and
evaporated to dryness. Dried extracts were reconstituted in
200 ll HPLC grade Methanol and stored at 70 C until assay.
2.2. RP-HPLC analysis
Gliotoxin was detected using a reversed phase HPLC (Spectra-
Physics). Gradient elution was performed with Solvent A consisting
of 0.1% (v/v) trifluoroacetic acid in 5:95 acetonitrile:HPLC grade
water (Sigma–Aldrich) and Solvent B consisting of 0.1% (v/v) triflu-
oroacetic acid in 99.9% acetonitrile. Gliotoxin extracts (20 ll) were
injected onto the C18 column (Hewlett Packard). All cultures were
grown up in triplicate and each one analysed in duplicate. Average
values were compared to a standard curve (0–1.0 lg gliotoxin) and
gliotoxin quantified as micrograms of gliotoxin per milligram of
mycelia produced ±standard deviation.
2.3. Protein extraction
A. fumigatus ATCC26933 (1  105 cfu/ml) was grown for 24 h in
Sabouraud media (50 ml cultures), at 37 C with shaking at
200 rpm. After 24 h, gliotoxin (700 lg) dissolved in methanol
was added to the cultures (n = 3). As a control, methanol onlywas added to parallel cultures (n = 3). After 4 h incubation, mycelia
were harvested, filtered under pressure, washed with PBS and
resuspended in lysis buffer (100 mM Tris–HCl, 50 mM NaCl,
20 mM EDTA, 10% (v/v) glycerol, 30 mM DTT, 1 mM PMSF and
1 lg/ml pepstatin A pH 7.5; 3 ml of lysis buffer per gram of myce-
lia). Lysis was accomplished by grinding in liquid N2 followed by
brief sonication on ice. Mycelial lysates were centrifuged
(10,000g; 30 min) to remove cell debris and the subsequent super-
natants analysed by 2D-PAGE following TCA/acetone precipitation
(Carberry et al., 2006).
2.4. Protein quantification
Protein was quantified using Bradford reagent (BioRad Labora-
tories) with BSA used as a standard protein.
2.5. Two-dimensional electrophoresis
Extracts containing 250 lg protein were resuspended in 8 M
Urea, 2 M Thiourea, 4% (w/v) CHAPS, 1% (v/v) Triton-X-100,
10 mM Tris-HC1, 65 mM DTT, 0.8% pH 4–7 carrier ampholytes
and loaded onto Immobiline Dry strips (GE Healthcare) in the pH
range 4–7. Following IEF on an IPGphor II, gels were equilibrated
in reducing buffer (50 mM Tris–HCl, 6 M Urea, 2% (w/v) SDS, 30%
(v/v) Glycerol, 2% (w/v) DTT, pH 6.8) for 20 min followed by equil-
ibration in alkylation buffer (50 mM Tris–HCl, 6 M urea, 2% (w/v)
SDS, 30% (v/v) glycerol, 2.5% (w/v) iodoacetamide, pH 6.8) for a fur-
ther 20 min. The equilibrated strips were placed on homogenous
12% SDS–PAGE gels and electrophoresed overnight at 100 V using
a Protean Xi-II Cell (Bio-Rad Laboratories). Resulting gels were
stained with Coomassie Brilliant Blue R and scanned using a Ty-
phoon Trio Variable Mode Imager (GE Healthcare, Freiburg, Ger-
many). Three replicate gels of each, treated and untreated were
submitted for analysis using the Image Master Platinum software
(GE Healthcare, Freiburg, Germany) to identify differentially regu-
lated spots. The protein spots of interest on each gel were detected,
normalised, edited and manually matched to a reference gel
(Fig. 1A).
2.6. MALDI-ToF mass spectrometry
Selected proteins were excised from 2D-PAGE gels using an
automated spot cutter (GE Healthcare, Freiburg, Germany), di-
gested with trypsin and analysed as previously described (Carberry
et al., 2006). Mass spectrometry was carried out using an EttanTM
MALDI-ToF mass spectrometer (GE Healthcare, Freiburg, Ger-
many), internal calibrants, Angiotensin III (Sigma–Aldrich) and
ACTH fragment 18–39 (Sigma–Aldrich), were used to calibrate all
spectra. Protein identification was carried out either by m/z data
interrogation of a (I) local FASTA version of the annotated A. fumig-
atus genome available at http://www.cadre-genomes.org.uk/ and
(II) Mascot™ nrNCBI database (Mabey et al., 2004).
2.7. GSH/GSSG and superoxide dismutase activity determination
Intracellular glutathione was measured using the method of
Thön et al. (2010) and Rahman et al. (2006), with modifications.
A. fumigatus ATCC26933 and DgliT (Schrettl et al., 2010), respec-
tively, were cultured for 21 h in AMM before addition of gliotoxin
(5 lg/ml final) for 3 h. Mycelia were harvested through miracloth
and dried. Mycelia (500 mg) in 5% (w/v) SSA (500 ll) were bead-
beaten at 30 Hz for 5 min followed by centrifugation at 12,000g
for 10 min at 4 C. Supernatants were removed, covered in tinfoil
and neutralised using triethanolamine. All samples were diluted
(1/10–1/30) in 125 mM sodium phosphate, 6.3 mM EDTA, pH 7.5
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Fig. 1. 2D-PAGE analysis of A. fumigatus challenged with exogenous gliotoxin (14 lg/ml) resulted in the identification of 27 proteins that were differentially regulated in
response to the exogenous gliotoxin. (A) Proteins were separated across the entire pI range of pH 4–7 strips and are present from less than 16 kDa up to over 100 kDa.
Numbered spots correspond to protein numbers in Tables 2 and 3. (B) Zoomed image of Cu, Zn superoxide dismutase de novo expression and up-regulated Asp f3 expression.
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(100 mM Tris-HCl, 50 mM NaCl, 20 mM EDTA, 10% (v/v) glycerol,
30 mM DTT, 1 mM PMSF, and 1 lg/ml pepstatin A, pH 7.5) and
quantified by Bradford Assay. 2-vinylpyridine (2 ll, 1/10 in assay
buffer) was added for GSSG determination, incubated at room tem-
perature for 1 h before triethanolamine (6 ll) was added to neu-
tralise the 2-vinylpyridine. All samples were incubated for
10 min at room temperature prior to assay. Then, blanks/stan-
dards/samples (20 ll) were added to 96-well microtiter plates fol-
lowed by 10 mM dithionitrobenzoic acid (DTNB) containing 1 unit
glutathione reductase and left for 30 s. NADPH (5 mM) was added
to each well, microplates gently shaken and A412 nm measured
after 90 s. Superoxide dismutase activity was determined in myce-
lial protein lysates (n = 3 each), obtained following mycelial incu-
bation with and without gliotoxin (14 lg/ml) for 4 h. Superoxide
dismutase assays were carried out as described by Raimondi
et al. (2010), except that nitroblue tetrazolium was used instead
of cytochome c.
2.8. Plate assays
For plate assays, 103–105 freshly harvested conidia of various
Aspergillus species, including A. nidulans, A. flavus, A. niger, A. ory-
zae, A. terreus, Neurospora crassa, Cochliobolus heterostrophus andFusarium graminearum were point inoculated on plates containing
gliotoxin in a range of 0, 0.1–30 lg/ml. As controls, A. fumigatus
wild-type ATCC46645 and DgliT (Schrettl et al., 2010) were used.
The diameter of the fungal colonies was determined after 72 h
and normalised to the diameter on plates without the addition of
gliotoxin. For experiments utilising S. cerevisiae, strain background
BY4741 (MATa: his3D1: leu2D0: met15D0: ura3D0) and deletion
derivatives were used throughout. Yeast strains deleted for SOD1
and GSH1were purchased from Euroscarf. Spot growth assays were
carried out by diluting an overnight culture of cells in fresh YPD
medium to 1  106 cells/ml. Cells were then grown to exponential
phase to a density of 3  106 cells/ml. Cells were then re-sus-
pended in YPD to a density of 5  106 cells/ml and transferred to
a microtiter plate. Following a series of 1 in 5 dilutions, cells were
transferred to YPD plates using a multi-pronged replicator and
incubated at 30 C for 2–3 days. GSH1 coding region ±500 bp was
cloned into pRS315 (LEU2) by gap repair and efficacy of the con-
struct confirmed by sequencing.2.9. ctsD deletion in A. fumigatus DgliT
An aspartic protease is encoded by A. fumigatus ctsD
(AFUA_4G07040; Vickers et al., 2007). To generate A. fumigatus
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used, with modifications. Briefly, A. fumigatus DgliT46645 (Schrettl
et al., 2010) was co-transformed with two DNA constructs, each
containing an incomplete fragment of the gliotoxin oxidoreductase
gene, gliT (Schrettl et al., 2010; Scharf et al., 2010) fused to 1.5 kb,
and 1.7 kb of ctsD 50 and 30 flanking sequences, respectively. These
marker fragments shared a 242 bp overlap within the gliT cassette,
which served as a potential recombination site during transforma-
tion. Two rounds of PCR generated each fragment (Table 1). First,
each flanking region was amplified from A. fumigatus ATCC46645
genomic DNA using primer ogliT-1 and ogliT-2 for flanking region
A (1.5 kb), and ogliT-3 and ogliT-4 for flanking region B (1.7 kb).
After purification, the fragments were digested with RsrII and PsiI,
respectively. gliT was PCR amplified from A. fumigatus ATCC46645
genomic DNA and inserted into TOPO cloning vector (Invitrogen).
gliT selection marker was removed from the TOPO cloning vector
following double restriction digest with RsrII and PsiI and ligated
with the two flanking regions A and B described above. Subse-
quently, two overlapping fragments were amplified from the liga-
tion products using primers ogliT-5 and ogliT-6 for fragment C
(2.1 kb) and primers ogliT-7 and ogliT-8 for fragment D (2.2 kb).
For generation of DctsD, A. fumigatus DgliT46645 protoplasts were
transformed simultaneously with the overlapping fragments C
and D, as described by Schrettl et al. (2010). Subsequent selection
was performed on Aspergillus Minimal Medium (AMM) with 0.7%
(w/v) agar including 1 M sucrose as an osmotic stabiliser and con-
taining gliotoxin (30 lg/ml). Southern analyses, to confirm gliT
insertion at the ctsD locus was performed using a digoxigenin
(DIG)-labelled probe, generated using primers ogliT-5 and ogliT-2,
against the 50-flanking region of ctsD following AflIII restriction di-
gest of A. fumigatus transformant genomic DNA. Further Southern
analyses, via XbaI digestion of A. fumigatus transformant genomic
DNA, to confirm the loss of ctsD and acquisition of the gliT, were
undertaken using DIG-labelled ctsD and gliT probes prepared by
PCR using primers ogliT-9 and ogliT-10 for ctsD and ogliT-11 and
ogliT-12 for the gliT probe, respectively. RT-PCR analyses were per-
formed to confirm loss of ctsD expression and assessment of gliT
expression using primers ogliT-13 and ogliT-14 for ctsD mRNA
analysis and ogliT-7 and ogliT-6 for gliT mRNA analysis.Table 1
Primers used in this study.
Primer Sequence 50–30 Use(s)
ogliT-1 AAAGGCCATGCGAGCTACTA Flanking region A
ogliT-2a CCCGGTCCGAATCTATGGTCGC Flanking region A,
50-flanking ctsD probe
ogliT-3b CCTTATAAGCATTGATGGGTC Flanking region B
ogliT-4 CTCTCTATCAGCGGGAAAAC Flanking region B
ogliT-5 CGCCAATGTGACAGAGATCA Overlapping fragment C,
50-flanking ctsD probe
ogliT-6 GACACCCACGGTCTCCTG Overlapping fragment C, gliT
RT-PCR
ogliT-7 ACTCCACCATCCAGTTCCAG Overlapping fragment D, gliT
RT-PCR
ogliT-8 AGTCCGGATTCGACGTACTG Overlapping fragment D
ogliT-9 TTTCTCTCGCCTCCACAGTT ctsD Probe
ogliT-10 TTGTAGCTAAGGCCCGAGAA ctsD Probe
ogliT-11 CTACTCTCGCGCATACCACA gliT Probe
ogliT-12 GCTCCTGATCGAGACGAAAC gliT Probe
ogliT-13 GAATGGTACGCCTTGTCGTT ctsD RT-PCR
ogliT-14 TTGTAGCTAAGGCCCGAGAA ctsD RT-PCR
Calm Fc CCGAGTACAAGGAAGCTTTCTC calm RT-PCR
Calm Rc GAATCATCTCGTCGATTCGTCGT
CTCAGT calm RT-PCR
a RsrII restriction site underlined.
b PsiI restriction site underlined.
c Burns et al. (2005).3. Results
3.1. Determination of media-dependence of gliotoxin production in A.
fumigatus
The concentration of gliotoxin in Sabouraud and MEM/FCS cul-
ture supernatants was determined to be 1.35 ± 0.3 lg and
23.65 ± 1.3 lg per mg mycelia, respectively. Thus, a 17-fold differ-
ence in gliotoxin production was evident which was directly re-
lated to culture medium composition. Moreover, this observation
facilitated evaluation of the effect of increased extracellular glio-
toxin levels on A. fumigatus, against a background of minimal glio-
toxin biosynthesis and secretion.3.2. Exogenous gliotoxin alters specific protein expression in A.
fumigatus
Following exposure of A. fumigatus in Sabouraud media (24 h) to
control conditions (methanol) and elevated gliotoxin (700 lg in
methanol) addition, mycelia were harvested after 4 h and lysed,
followed by 2D-PAGE, comparative protein expression analysis
and MALDI-ToF mass spectrometry to facilitate protein identifica-
tion (Fig. 1A and B, Tables 2 and 3). Overall, perturbation in the
expression of at least 27 distinct proteins was detected, comprising
of both up-regulation (18; 64%) and down-regulation (9; 33%) in
response to gliotoxin exposure. De novo expression of a Cu, Zn
superoxide dismutase (AFUA_5G09240; SOD; Fig. 1B), a short chain
dehydrogenase (AFUA_4G08710) and a eukaryotic translation
elongation factor b1 subunit (AFUA_1G11190) were also clearly
observed following gliotoxin exposure (Table 2). Interestingly,
superoxide dismutase activity was significantly elevated
(p < 0.03) from 0 (pre-exposure) to 92 ± 41 U/mg in cultures ex-
posed to gliotoxin, in accordance with proteomic data. Moreover,
reactive oxygen species (ROS) production, also accompanied myce-
lial exposure to gliotoxin (data not shown). Three proteins (puta-
tive adenine phosphoribosyltransferase, uridylate kinase and an
aminopeptidase) exhibited between 10–20-fold increased expres-
sion, while three proteins: Vip1, a putative thiazole biosynthesis
enzyme and allergen Asp f3 (Fig. 1B) were up-regulated 9.49,
7.03 and 5.8-fold, respectively. In addition, expression of eight
other proteins, including a putative heat shock protein, Sti1, and
thiamine biosynthesis protein, Nmt1, was induced by 1.9–3.0-fold.
Overall, identification of proteins whose expression was up-regu-
lated by gliotoxin exposure was confirmed by overall sequence
coverage ranging from 17.6–49.3%. The expression of nine proteins
was found to be significantly (p < 0.05) down-regulated following
gliotoxin exposure (Table 3). Mycelial catalase (AFUA_3G02270)
expression reduced by over 40-fold, while that of ATP-citrate lyase
(AFUA_6G10660) and fumaryl acetoacetate hydrolase (FahA;
AFUA_2G04230) diminished by over 26 and 21-fold, respectively.
The expression of the remaining six proteins, including antioxidant
protein LsfA (peroxredoxin; AFUA_4G08580) and dehydrogenases/
oxidoreductases, ranged from a 4.2–9.6-fold reduction, compared
to control conditions.3.3. Intracellular GSH levels are significantly altered in A. fumigatus
DgliT
GSH levels were significantly elevated (p < 0.05) in A. fumigatus
DgliT compared to wild-type (Fig. 2A) which suggests that elevated
GSHmay potentiate the autotoxic effects of gliotoxin. Differences in
intracellular GSH levels remained significantly different (p < 0.05),
in A. fumigatuswild-type andDgliT, even in the presence of gliotox-
in (5 lg/ml). However addition of gliotoxin, to either A. fumigatus
wild-type or DgliT, resulted in a diminution in intracellular GSH
Table 2
Selected proteins undergo significantly increased expressiona following exposure of A. fumigatus ATCC26933 to gliotoxin.b Proteins are listed according to fold increase in
expression.
Proposed/actual function Fold increase % Sequence coverage Mass (Da) CADRE I.D.c Spot No.
Cu, Zn superoxide dismutase (+) Unique 33.5 16,361 AFUA_5G09240 725
Short chain dehydrogenase (+) Unique 29.6 30,928 AFUA_4G08710 779
Eukaryotic translation elongation
Factor 1b subunit (+) Unique 25.9 30,142 AFUA_1G11190 714
Adenine phosphoribosyltransferase 20.5 33.6 23,621 AFUA_7G02310 715
Uridylate kinase 10.3 33.2 25,560 AFUA_7G03990 722
Aminopeptidase 10.1 26 106,227 AFUA_4G09030 693
Vip1 proteind,e 9.5 24.2 28,265 AFUA_2G10030 777
Vip1 proteind,e 7.0 44.2 28,265 AFUA_2G10030 776
Thiazole biosynthesis enzyme 7.0 27.7 35,492 AFUA_6G08360 814
Allergen Asp F3 5.8 30.4 18,453 AFUA_6G02280 765
Nitroreductase family protein 3.0 49.3 24,314 AFUA_5G09910 753
Unknown function proteind,e 2.9 30.8 25,439 AFUA_5G14680 749
Heat shock protein (Sti1), putative 2.9 17.6 65,031 AFUA_7G01860 708
Allantoicase 2.7 21.3 46,273 AFUA_3G12560 740
Mitochondrial processing
Peptidase b subunit 2.7 31.5 53,270 AFUA_1G14200 768
Glycerol dehydrogenase 2.5 25.8 36,828 AFUA_4G11730 691
Unknown function proteind,e 2.1 37.9 25,439 AFUA_5G14680 747
Thiamine biosynthesis protein Nmt1 1.9 33.9 38,323 AFUA_5G02470 764
Phosphoglycerate kinase 1.9 34.2 44,761 AFUA_1G10350 758
a p < 0.05.
b GliT (AFUA_6G09740) expression was also significantly increased, 2.5–3.5-fold (Schrettl et al., 2010).
c CADRE I.D: CADRE Identification (Mabey et al., 2004).
d,e Vip1 protein and unknown function protein were each detected in two adjacent protein spots, respectively.
Table 3
Selected proteins undergo significantly decreased expressiona following exposure of A. fumigatus ATCC26933 to gliotoxin. Proteins are listed according to fold decrease in
expression.
Proposed/actual function Fold decrease % Sequence coverage Mass (Da) CADRE I.D.b Spot No.
Mycelial catalase 1 41.6 20.3 79,910 AFUA_3G02270 827
ATP-citrate lyase 26.2 30.7 52,918 AFUA_6G10660 790
Fumarylacetoacetate hydrolase FahA 21.2 18.3 46,817 AFUA_2G04230 781
Aminopeptidase B 9.6 7.9 108,707 AFUA_5G04330 831
Aldo–keto reductase family 7 protein 9.0 37.2 35,489 AFUA_5G02020 697
Aldehyde dehydrogenase 8.9 25.6 53,759 AFUA_7G01000 795
Alcohol dehydrogenase, Zn containing 8.5 47.1 37,854 AFUA_1G04620 779
Anti-oxidant protein LsfA peroxiredoxin 6.9 31.9 23,393 AFUA_4G08580 775
GMC oxidoreductase 4.2 17.6 72,151 AFUA_3G01580 706
a p < 0.05.
b CADRE I.D, CADRE identification (Mabey et al., 2004).
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increase in GSSG. Although not statistically significant, these trends
were reproducible, and suggest formation of mixed gliotoxin-GSH
disulphides. Moreover, the GSH/GSSG ratio in A. fumigatus
ATCC26933 was 8.15, while it was increased to 47.5 in A. fumigatus
DgliT. This dramatic increase in ratio in A. fumigatus DgliT must be
caused by the significant increase (p < 0.05) in GSH levels as there
was no observed difference in the GSSG levels. Relatedly, A. fumig-
atusDgliTwas significantly more resistant to the effects of diamide,
a GSH scavenger, than either wild-type or gliTC strains (Fig. 2C),
thereby providing complementary support for the observed GSH
levels. Future work will investigate the effects of gliotoxin on GSH
reductase and peroxidase activities, respectively, to further eluci-
date the interplay between GliT, gliotoxin and these catalytic
functions.3.4. Gliotoxin disrupts the intracellular redox balance in S. cerevisiae
Fig. 3A shows that growth of S. cerevisiae BY4741 (wild-type) is
impeded by exposure to exogenous gliotoxin (8 lg/ml) and that S.
cerevisiae Dsod1 and Dyap1 exhibit increased hypersensitivity to
exogenous gliotoxin compared to the wild-type strain. Thisobservation indicates that gliotoxin induced an oxidative stress in
S. cerevisiae and may cause superoxide formation. Importantly,
compared to wild-type, no growth difference was observed when
S. cerevisiaeDctt1,Dgsh2 orDglr1were exposed to identical gliotox-
in concentrations (data not shown). To further explore the
mechanism underlying gliotoxin-mediated growth inhibition, S.
cerevisiae Dgsh1, which is deficient in intracellular GSH (Lee et al.,
2001), and Dgsh1:GSH1, the complemented strain, were exposed
to gliotoxin. It can be seen in Fig. 3B that S. cerevisiae Dgsh1 exhib-
ited increased resistance to exogenous gliotoxin (16 lg/ml) com-
pared to wild-type and that re-introduction of GSH1 in the
deletion strain restored gliotoxin sensitivity. This observation sug-
gests that decreased intracellular GSH levels may protect S. cerevisi-
ae against gliotoxin by attenuating production of intracellular
reduced gliotoxin (gliotoxin-(SH)2).3.5. Gliotoxin inhibits fungal growth
The proposed use of gliT as a selection marker during transfor-
mation in fungi relies on the sensitivity of these fungal species to
gliotoxin (Schrettl et al., 2010). Hence, it was necessary to test







Fig. 2. Assessment of redox status in A. fumigatus DgliT. (A) Significantly elevated
GSH is evident in A. fumigatus DgliT compared to wild-type and A. fumigatus gliTc.
This may sensitise the mutant to gliotoxin. (B) GSH and GSSG levels in A. fumigatus
ATCC26933 and DgliT in the absence and presence of gliotoxin (GT) for 3 h. Under
basal conditions, there is a significant increase (p < 0.05) in GSH levels in A.
fumigatus DgliT compared to A. fumigatus ATCC26933. Gliotoxin addition depletes
GSH in both strains without affecting the significant difference (p < 0.05) between
GSH levels in both strains. (C) A. fumigatus DgliT is significantly more resistant to
the GSH-scavenging agent, diamide. This is most likely a consequence of elevated
intracellular GSH. In both cases, complementation restored the wild-type
phenotype.
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different concentrations of gliotoxin. For plate assays, 103–105
freshly harvested conidia of various Aspergillus species, including
A. nidulans, A. flavus, A. niger, A. oryzae, A. terreus,N. crassa, C. hetero-
strophus and F. graminearum were point inoculated on plates con-
taining gliotoxin in a range of 0, 0.1–30 lg/ml. Statistically
significant (p < 0.001 using Bonferronis Multiple Comparison Test),
gliotoxin-mediated growth inhibtion of A. nidulans, A. terreus, A. ni-
ger, C. heterostrophus and N. crassa was observed at 5 lg/ml glio-
toxin (Fig. 4A and B). This establishes all of these strains as
suitable for transformation with gliT to facilitate transformant
selection on gliotoxin. Growth of A. flavus, F. graminarium and A.
oryzae was significantly inhibited (p < 0.001) at 10 lg/ml gliotoxin
(Fig. 4). Again, this indicates suitability of these as target strains for
transformation with gliT to facilitate transformant selection ongliotoxin, albeit necessitating the use of higher concentrations of
gliotoxin to facilitate selection.3.6. Targeted gene deletion in A. fumigatus can be detected by recovery
of gliotoxin resistance
A. fumigatus ATCC46645 ctsD (AFUA_4G07040) encodes an
aspartic protease which was found to be expressed in minimal
and proteinaceous media only, and does not play any role in glio-
toxin metabolism (Vickers et al., 2007; Gardiner and Howlett,
2005). After confirmation of ctsD expression in gliotoxin-sensitive
A. fumigatus DgliT46645, targeted deletion of ctsD was undertaken
using a bipartite strategy (Nielsen et al., 2006) whereby gliT
introduction at the ctsD locus (Fig. 5A), followed by selection of
transformants on gliotoxin-containing media (30 lg/ml) was
attempted (Fig. 5B). Southern blot analysis of A. fumigatus ATCC
46645 or DgliT46645, using a probe for the 50 flanking region of ctsD,
yielded a fragment size of 3530 bp at the ctsD locus, whereas trans-
formants (n = 10) which had recovered gliotoxin resistance yielded
a fragment at 2508 bp thereby confirming disruption of ctsD. Fur-
thermore, a fragment of 4832 bp, which contained the ctsD open
reading frame was absent in all 10 transformants when a ctsD cod-
ing region probe was employed for Southern analysis (Fig. 5C).
Concomitant re-introduction of the gliT coding sequence at the ctsD
locus, detected using a gliT-specific probe, in A. fumigatus DgliT,
was evident as shown by appearance of a fragment at 5102 bp
(corresponding signals for A. fumigatus ATCC 46645 and DgliT46645,
were 6403 bp and no signal, respectively) (Fig. 5D). Both gliT and
ctsD expression was evident in A. fumigatus ATCC 46645, however
as assessed by RT-PCR, ctsD expression was not evident in A. fumig-
atus DctsD46645 but was detectable in A. fumigatus DgliT46645
(Fig. 5E). Conversely, gliT was expressed in A. fumigatus DctsD46645
which confirmed that successful ctsD deletion using gliT re-intro-
duction into A. fumigatus DgliT46645, with selection for gliotoxin
resistance, had occurred (Fig. 5E).4. Discussion
Little is known about the effect of gliotoxin on, or in, fungi.
Analysis of A. fumigatus culture supernatants revealed gliotoxin
production to be media specific, with a 17-fold concentration dif-
ference between two specific culture media. 2D-PAGE analysis of
A. fumigatus mycelia challenged with exogenous gliotoxin for 4 h
after 24 h growth in Sabouraud media (low endogenous gliotoxin
production) led to the identification of 27 differentially-regulated
proteins, 18 which exhibited increased expression, and 9 which
underwent decreased expression in the presence of gliotoxin. Only
proteins with a t-test score of p 6 0.05 were accepted as significant.
Our data further demonstrates dysregulation of intracellular GSH
levels in the absence of A. fumigatus gliT, a possible consequence
of which is elevated sensitivity to exogenous gliotoxin. Because
of the increased sensitivity or resistance of S. cerevisiae gene dele-
tants to gliotoxin, along with sensitivity of a range of fungal species
to gliotoxin, we suggest gliotoxin exposure as a standard pheno-
typic screen in functional genomic studies. Whether gliotoxin is
primarily an antifungal, or a protective molecular species, is dis-
cussed below – along with the potential for gliT/gliotoxin as an
alternative selection marker system for fungal transformation.
Cu, Zn superoxide dismutase (Cu, Zn SOD), (AFUA_5G09240)
was expressed de novo in the presence of exogenous gliotoxin in
A. fumigatus. Interestingly, gliotoxin has been shown to produce
superoxide radicals in mast cells (Niide et al., 2006), and the de
novo expression of Cu, Zn SOD suggests that gliotoxin addition
may have an identical effect in A. fumigatus. Moreover, Cu, Zn
SOD was previously identified by Lessing et al. (2007), to be
Fig. 3. Effect of gliotoxin on S. cerevisiae BY4741 (wild-type), oxidative stress and glutathione-deficient mutants. (A) Absence of sod1 and yap1 result in increased sensitivity to
exogenous gliotoxin. (B) S. cerevisiae sensitivity to gliotoxin is dependent on GSH1 presence.
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although not essential for virulence (Lambou et al., 2010), the en-
zyme appears to play a role in ROS and protection against gliotox-
in. Interestingly, SOD expression was also increased in A. flavus
during the production of another mycotoxin, aflatoxin (O’Brian
et al., 2007) and production of aflatoxin has been linked with great-
er oxygen requirements and high levels of ROS (Narasaiah et al.,
2006) as has also been suggested for gliotoxin (Watanabe et al.,
2004). A. fumigatus SOD has been shown to be reactive to sera from
aspergillosis patients (Holdom et al., 1996), and is present on the
cell wall and in culture media. This may show a possible protective
role against the oxidative burst mechanism of neutrophils in re-
sponse to A. fumigatus infection (Hamilton et al., 1996). Bruns
et al. (2010) also noted that Cu, Zn SOD gene expression was signif-
icantly up-regulated in A. fumigatus during biofilm formation. De
novo expression of eukaryotic elongation factor 1b subunit
(AFUA_1G11190) was also observed in A. fumigatus mycelia. This
protein was previously identified to be abundant in A. fumigatus
conidia but was found to be relatively weakly immunogenic (Asif
et al., 2006). Sugui et al. (2008) demonstrated that short chain
dehydrogenase expression (AFUA_4G08710) was significantly up-
regulated in conidia, but not hyphae, upon exposure to neutrophils
from either normal or CGD donors. Thus, the de novo expression of
this protein in response to gliotoxin exposure may be due similar-
ities between the intracellular oxidative stress program induced by
neutrophils and gliotoxin, respectively. Significantly, cognate
mRNA expression of six (adenine phosphoribosyltransferase
(APRT), aminopeptidase, Vip1 protein, heat shock protein (Sti1),
glycerol dehydrogenase (GldB) and thiamine biosynthesis protein
(Nmt1); Table 2) of the 15 proteins whose expression is induced
by gliotoxin, was also significantly up-regulated following conidial
exposure to airway epithelial cells (Oosthuizen et al., 2011). Ele-
vated expression of two enzymes involved in nucleotide biosyn-
thesis (APRT and uridylate kinase) was also evident upon
gliotoxin exposure. Khalaj et al. (2011) noted a 20% reduction in
uridylate kinase expression in an annexin disruptant (DanxC4)
and although no functional role was assigned to altered uridylate
kinase expression, these authors noted that alterations in stress re-
sponse related proteins suggested an oxidative stress response in
the mutant. Allergen Asp f3 (AFUA_6G02280) is a thiol-specific
peroxiredoxin that reduces hydroperoxides to protect against oxi-
dative damage (Fig. 1B). It is a known fungal allergen, is identical toperoxisomal membrane protein Pmp20 and, as a vaccine, has re-
cently been demonstrated to induce cell-mediated protection
against Aspergillus infection (Mabey et al., 2004; Diaz-Arevalo
et al., 2011). Pmp20 characterisation in Candida boidinii suggested
that it functioned to degrade ROS generated at peroxisomal mem-
brane surface, such as lipid hydroperoxides (Horiguchi et al., 2001).
Interestingly, expression of several stress-induced proteins was
decreased in the presence of exogenous gliotoxin including myce-
lial catalase and antioxidant protein, peroxiredoxin LsfA. Mycelial
catalase (AFUA_3G02270) expression decreased nearly 42-fold in
expression. Lessing et al. (2007) have shown that hydrogen perox-
ide exposure down-regulates expression of a distinct catalase
(AFUA_2G00200) but did not mention AFUA_3G02270. Nonethe-
less, their observation is in accordance with our findings that oxi-
dative stress conditions may, unexpectedly, suppress catalase
levels. Recently, gliotoxin was identified as an antioxidant in mam-
malian cells, functioning as a peroxiredoxin in the thioredoxin re-
dox system (Choi et al., 2007). Consequently, we speculate that
exogenous gliotoxin may fulfil this biological function in A. fumig-
atus, resulting in diminished requirement for mycelial catalase.
Peroxiredoxin LsfA (AFUA_4G08580) is a putative alkyl hyderoper-
oxide reductase/thiol specific antioxidant, and as such, may have
several predicted functions such as antioxidant and oxidoreductase
activities. In this case, it appears that gliotoxin exposure down-reg-
ulates, LsfA levels (approximately seven-fold), while H2O2 presence
induces expression (Lessing et al., 2007). Overall, the differential
regulation of 27 proteins (including one protein of unknown func-
tion, AFUA_5G14680) in response to exogenous gliotoxin suggests
a hitherto unknown complex interaction between gliotoxin and A.
fumigatus.
Increased expression (2.5–3.5-fold) of GliT (gliotoxin oxidore-
ductase; AFUA_6G09740), a component of the gliotoxin biosyn-
thetic cluster was previously reported by us (Schrettl et al.,
2010). Interestingly, Schrettl et al. (2008) also observed indepen-
dent regulation of gliT during comparative transcriptomics study
of A. fumigatus wild-type and a mutant deficient in control of sid-
erophore biosynthesis (DsreA). Moreover, Bruns et al. (2010) de-
tected increased A. fumigatus GliT expression during biofilm
formation using a proteomic strategy, along with the detection of
additional gli genes by transcriptomic analyses. Schrettl et al.
(2010) suggested that gliotoxin addition to fungal cultures resulted






















(C) (D)Fusarium graminearum Cochliobolus heterostrophus
Fig. 4. (A) Sensitivity of a range of biomedically and commercially-important fungal strains to gliotoxin. (B) Visualisation of A. niger sensitivity to gliotoxin (0–30 lg/ml). (C
and D) Growth of both C. heterostrophus and F. graminearum is significantly inhibited by exogenous gliotoxin (p < 0.001). These data indicate that all of the above strains may
be suitable for use with gliT/gliotoxin selection marker system for both gene deletion studies and heterologous protein expression in fungi.
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nificant elevation of intracellular GSH, with concomitant resistance
to diamide, compared to A. fumigatus wild-type. This observation
suggests that elevated intracellular GSH may actually potentiate
the action of gliotoxin on A. fumigatus DgliT, yet simultaneously
confer increased resistance towards the GSH-scavanging oxidant,diamide. Interestingly, A. fumigatus DgliT did not exhibit increased
sensitivity to H2O2 (Schrettl et al., 2010), which suggests distinct
patterns of redox stress in A. fumigatus. In this regard, Lessing
et al. (2007) and Qiao et al. (2008) observed significantly increased
sensitivity against H2O2 and menadione, but not against diamide,





5’ probe ctsD ORF probe 
gliT ORF probe 
Fig. 5. Disruption of a ctsD in A. fumigatus DgliT46645 using gliT re-introduction at ctsD locus, followed by transformant selection on gliotoxin. (A) Schematic diagram showing
probe hybridisation regions and predicted restriction fragment sizes. Southern blot analysis following: (B) AflIII digestion and 50 ctsD detection probe. Expected bands: A.
fumigatus ATCC46645 orDgliT: 3530 bp,DctsD::gliT: 2508 bp. Appearance of a band at 2508 bp indicates disruption of ctsD. (C) XbaI digestion and ctsD coding sequence probe.
Expected bands: A. fumigatus ATCC46645 or DgliT: 4832 bp DctsD::gliT: no band. Absence of band at 4832 bp in lanes 4–7 indicates ctsD coding sequence is absent. D. XbaI
digestion and gliT coding sequence probe. Expected bands: A. fumigatus ATCC46645 or DctsD::gliT: 6403 or 5102 bp, respectively, DgliT: no band. gliT coding sequence re-
introduced in DgliT at ctsD locus, as evidenced by appearance of band at 5102 bp. Key: 1. Markers. 2. A. fumigatus ATCC46645 3. A. fumigatus DgliT46645 4. A. fumigatus
DctsD::gliTc 5. A. fumigatus DctsD::gliTc 6. A. fumigatus DctsD:gliTc 7. A. fumigatus DctsD::gliTc. 8. Markers. E. Expression analysis, using duplicate cultures, of gliT and ctsD,
respectively, using RT-PCR. Top panel: ctsD expression is absent in DctsD. Middle panel: gliT expression is restored in strain DctsD:gliTc. Lower panel: RNA loading control.
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Dsod1 and Dyap1 growth, respectively, is inhibited to a greater
extent than BY4741 (wild-type). This increased sensitivity of S.
cerevisiaeDsod1 is in accordance with our observation that gliotox-
in up-regulates Cu, Zn SOD expression in A. fumigatus and predictssuperoxide production is consequent to gliotoxin addition in both
fungal species. Moreover, the increased sensitivity to gliotoxin in S.
cerevisiae Dyap1 implies that this gene is also essential to protect
against gliotoxin-induced ROS. These data further the observations
of Chamilos et al. (2008) regarding the effects of gliotoxin on yeast
S. Carberry et al. / Fungal Genetics and Biology 49 (2012) 302–312 311mutants and future studies will explore the effects of gliotoxin on
A. fumigatus Dyap1. Our observation that S. cerevisiae Dgsh1, se-
verely deficient in GSH (Lee et al., 2001), exhibits greater resistance
to gliotoxin than wild-type – and that complementation with GSH1
restores wild-type levels of gliotoxin sensitivity - further under-
pins our proposal that intracellular GSH levels play an important
role in mediating gliotoxin cytotoxicity in fungi as has been noted
in animals cells by Bernardo et al. (2003).
Gliotoxin was originally investigated as an antifungal antibi-
otic (Johnson et al., 1943). Later, Losada et al. (2009) investigated
the presence of antifungal agents produced by Aspergillus spp and
detected gliotoxin in fungal co-culture extracts by LC-MS analy-
sis. Yet, the dramatic sensitivity to gliotoxin (10 lg/ml; 30 lM)
evident in the present work, whereby growth of three fungal spe-
cies (A. niger, N. crassa and C. heterostrophus) was completed
inhibited, was unexpected. Notably, all three strains lack the gli
cluster and do not possess a gliT ortholog which, at least in part,
explains this dramatic gliotoxin sensitivity compared to fungi
which possess the cluster with multiple copies of gliT (A. flavus)
(Patron et al. 2007; Fox and Howlett, 2008). Coleman et al.
(2011) noted the sensitivity of Candida albicans and Cryptococcus
neoformans to gliotoxin and A. fumigatus culture supernatants
(containing gliotoxin), and speculate about the role of gliotoxin
as a competitive factor during host colonisation by multiple fun-
gal species. However, an alternative hypothesis could be that
gliotoxin secretion represents a component of the defensive
armoury of A. fumigatus against host oxidants, and that the anti-
fungal activity is either accidental, or of more relevance in exter-
nal environments to facilitate niche competition. Interestingly,
Bruns et al. (2010) noted elevated levels of gliotoxin in A. fumig-
atus biofilms, compared to culture supernatants, and note that
this may represent an immunomodulatory strategy (Nishida
et al., 2005) on behalf of the organism. However, a more specific
interpretation is that a localised gliotoxin ‘‘corona’’ acts exter-
nally to dissipate host ROS. If this hypothesis is true, then A.
fumigatus would have to be able to withstand high local gliotoxin
concentrations, which can, in part, explain the protective proteo-
mic remodelling observed herein in response to exogenous glio-
toxin addition.
Gliotoxin sensitivity offers the possibility of using gliT as a dom-
inant selection marker for fungal transformation. Consequently,
the successful deletion of ctsD (Vickers et al., 2007) from A. fumig-
atus DgliT, using gliT reconstitution and selection on gliotoxin
proves this concept- at least in A. fumigatus. Further refinements
of this system, which involves use of a fungal-specific gene (gliT),
will involve use of self-excision mechanisms (Hartmann et al.,
2010) to release ptrA originally used for gliT deletion (Schrettl
et al. 2010) and investigation of the system in commercially impor-
tant strains (e.g., Trichoderma reesei; Steiger et al., 2011).
5. Conclusion
We have demonstrated that gliotoxin addition perturbs the pro-
teome of A. fumigatus and induces de novo Cu, Zn SOD expression.
Combined with observations of significantly elevated GSH levels in
A. fumigatus DgliT and the effects of gliotoxin on S. cerevisiae, we
conclude that gliotoxin induces redox stress in fungi, at least in
part mediated by superoxide anions and elevated GSH levels.
While the antifungal effects of gliotoxin are clear, our results are
also in accordance with a complex self-protection system, opera-
tive in A. fumigatus. Based on our observations, along with those
of Schrettl et al. (2010), Watanabe et al. (2004), Bruns et al.
(2010) and Coleman et al. (2011), we now hypothesise that this
system may be necessary to defend against high, localised gliotox-
in levels (Bruns et al., 2010), present during host colonisation- one
function of which may be external dismutation of host ROS. Finally,we demonstrate extreme gliotoxin sensitivity in a range of fungi,
the utility of gliT/gliotoxin for targeted gene deletion studies in A.
fumigatus, and suggest that gliotoxin sensitivity assays should be
incorporated into future functional genomic and proteomic studies
involving fungi.
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